US SEC removes legal obstacle to UBS’ crisis-resolution plan
WASHINGTON, July 8 (Reuters) – The U.S. Securities and Exchange Commission told UBS Group [RIC:RIC:UBSAG.UL] on Wednesday that…
Beazley shareholders approve Zurich’s $10.9 billion cash takeover
April 22 (Reuters) – London-listed specialty insurer Beazley (BEZG.L), opens new tab said on Wednesday shareholders approved Swiss…
Zurich Insurance’s property and casualty gross written premiums rise on data center boost
May 13 (Reuters) – Zurich Insurance (ZURN.S), opens new tab reported higher first-quarter gross written premiums for its…
Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
BERLIN, March 3 (Reuters) – Swiss pharmaceutical company Roche (ROG.S), opens new tab is aiming for a double-digit…
Roche boosts US presence with new $700 million North Carolina facility
May 12 (Reuters) – Roche Group (ROG.S), opens new tab said on Monday that it plans to invest…
Ethos rejects Novartis CEO, management pay as excessive
ZURICH, Feb 24 (Reuters) – Proxy advisory firm Ethos on Tuesday urged shareholders of Novartis (NOVN.S), opens new…
Roche sticks to German investment after Eli Lilly cuts
FRANKFURT, June 9 (Reuters) – The Swiss pharmaceutical and diagnostics giant Roche (ROPC.S), opens new tab said it…
Roche chairman still expects diagnostics hit from US tariffs
ZURICH, March 7 (Reuters) – Roche (ROG.S), opens new tab expects its agreement with the U.S. government will…
Colombia urges Glencore to discuss Cerrejon coal mine closure with local authorities
BOGOTA, May 8 (Reuters) – Colombia’s government on Friday said it will ask miner Glencore (GLEN.L), opens new…
Zurich Insurance wins over UK’s Beazley with sweetened $11 billion bid proposal
Beazley valued at up to 1,335 pence per share under new proposalBeazley board open to recommending Zurich’s proposalCompany…
UK’s FTSE 100 climbs on earnings boost, midcaps jump after BoE rate hold
April 30 (Reuters) – London’s FTSE 100 index rose on Thursday, with upbeat results from Rolls-Royce and Glencore…
Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
Item 1 of 2 The logo of Swiss drugmaker Novartis is seen at the company’s new cell and…